DEEPZERO (02723) has signed a strategic cooperation memorandum of understanding with Deloitte China.
Deep Intelligence (02723) announced that the company has signed a strategic cooperation memorandum with Deloitte Consulting (Shanghai) Co., Ltd. (Deloitte China). Deloitte China has long been committed to serving large enterprises in complex transformations and has accumulated extensive experience in AI strategic planning, industry insights, data governance, and organizational change.
DEEPZERO (02723) announced that the company has signed a strategic cooperation memorandum of understanding (the memorandum) with Deloitte Consulting (Shanghai) Co., Ltd. (Deloitte China). Deloitte China has long been dedicated to serving large enterprises in complex transformations and has accumulated deep experience in AI strategic planning, industry insights, data governance, and organizational change.
This strategic cooperation will combine Deloitte China's consulting capabilities with the company's enterprise decision-making AI agent products and implementation capabilities, linking transformation strategies to decision-making applications, creating a more competitive and scalable way for clients to implement enterprise AI. Both parties will collaborate throughout the entire process from strategic blueprint, scenario selection to product deployment and ongoing operation, focusing on joint solutions, co-creation with key clients, and industry practices.
To scale the implementation of enterprise AI, a trustworthy, measurable, and governable end-to-end capability system needs to be established, integrating key aspects such as data, knowledge, talent organization, and value creation. As a leading enterprise decision-making AI agent company, we have developed advanced intelligent agent products in AI-driven intelligent decision-making, growth operations, and marketing innovation, while accumulating profound technical capabilities. Deloitte China will leverage its expertise in industry insights, strategic consulting, and technological transformation to work hand-in-hand with our company to promote the deep integration of AI technologies and products in client scenarios, continuously advancing AI-enabled enterprise growth.
Related Articles

HK Stock Market Move | H&H INTL HLDG (01112) opened more than 13% higher after earnings, with mid-term net profit increasing by approximately 7.6 times year-on-year, and gross margins in three major business segments have risen.

HK Stock Market Move | CANSINOBIO (06185) opened nearly 13% higher after reaching a strategic cooperation agreement with Depp Biologics for mRNA personalized therapeutic tumor vaccines.

HK Stock Market Move | INNOVENT BIO (01801) surged over 6% in early trading, with a net profit growth exceeding 50% year-on-year in the first half of the year. The revenue target for 2030 is set at 35 billion to 40 billion yuan.
HK Stock Market Move | H&H INTL HLDG (01112) opened more than 13% higher after earnings, with mid-term net profit increasing by approximately 7.6 times year-on-year, and gross margins in three major business segments have risen.

HK Stock Market Move | CANSINOBIO (06185) opened nearly 13% higher after reaching a strategic cooperation agreement with Depp Biologics for mRNA personalized therapeutic tumor vaccines.

HK Stock Market Move | INNOVENT BIO (01801) surged over 6% in early trading, with a net profit growth exceeding 50% year-on-year in the first half of the year. The revenue target for 2030 is set at 35 billion to 40 billion yuan.

RECOMMEND





